Effects of Semax on Ca2+ responses of human neutrophils.
Astashkin
E I
EI
Sechenov Medical Academy, Moscow, Russia.
Bespalova YuB
Grivennikov
I A
IA
Smirnov
O N
ON
Glezer
M G
MG
Grachev
S V
SV
Myasoedov
N F
NF
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives / Q000494:pharmacology*; D002118:Calcium / Q000097:blood*; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D018696:Neuroprotective Agents / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D010446:Peptide Fragments / Q000494:pharmacology*; D019284:Thapsigargin / Q000494:pharmacology
D018696:Neuroprotective Agents; D010446:Peptide Fragments; D009240:N-Formylmethionine Leucyl-Phenylalanine; D019284:Thapsigargin; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone; D002118:Calcium